Intensive glycemic control and the prevention of cardiovascular events: Implications of the ACCORD, ADVANCE, and VA diabetes trials

Jay S. Skyler; Richard Bergenstal; Robert O. Bonow; John Buse; Prakash Deedwania; Edwin A.M. Gale; Barbara V. Howard; M. Sue Kirkman; Mikhail Kosiborod; Peter Reaven; Robert S. Sherwin

doi:10.2337/dc08-9026

Intensive glycemic control and the prevention of cardiovascular events: Implications of the ACCORD, ADVANCE, and VA diabetes trials

Jay S. Skyler, Richard Bergenstal, Robert O. Bonow, John Buse, Prakash Deedwania, Edwin A.M. Gale, Barbara V. Howard, M. Sue Kirkman, Mikhail Kosiborod, Peter Reaven, Robert S. Sherwin

Medicine, Cardiology Division

Research output: Contribution to journal › Article › peer-review

478 Scopus citations

Original language	English (US)
Pages (from-to)	187-192
Number of pages	6
Journal	Diabetes care
Volume	32
Issue number	1
DOIs	https://doi.org/10.2337/dc08-9026
State	Published - Jan 2009

Funding

P.R. has received research funding from Takeda and Amylin, has received speaker fees from Merck and Takeda, and is a VADT investigator and principal investigator of ancillary study to VADT.

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism
Advanced and Specialized Nursing

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2337/dc08-9026

Cite this

@article{49e90cc9eead420ba76a9aaec7c3de92,

title = "Intensive glycemic control and the prevention of cardiovascular events: Implications of the ACCORD, ADVANCE, and VA diabetes trials",

author = "Skyler, {Jay S.} and Richard Bergenstal and Bonow, {Robert O.} and John Buse and Prakash Deedwania and Gale, {Edwin A.M.} and Howard, {Barbara V.} and Kirkman, {M. Sue} and Mikhail Kosiborod and Peter Reaven and Sherwin, {Robert S.}",

note = "Funding Information: P.R. has received research funding from Takeda and Amylin, has received speaker fees from Merck and Takeda, and is a VADT investigator and principal investigator of ancillary study to VADT. ",

year = "2009",

month = jan,

doi = "10.2337/dc08-9026",

language = "English (US)",

volume = "32",

pages = "187--192",

journal = "Diabetes care",

issn = "0149-5992",

publisher = "American Diabetes Association Inc.",

number = "1",

}

TY - JOUR

T1 - Intensive glycemic control and the prevention of cardiovascular events

T2 - Implications of the ACCORD, ADVANCE, and VA diabetes trials

AU - Skyler, Jay S.

AU - Bergenstal, Richard

AU - Bonow, Robert O.

AU - Buse, John

AU - Deedwania, Prakash

AU - Gale, Edwin A.M.

AU - Howard, Barbara V.

AU - Kirkman, M. Sue

AU - Kosiborod, Mikhail

AU - Reaven, Peter

AU - Sherwin, Robert S.

N1 - Funding Information: P.R. has received research funding from Takeda and Amylin, has received speaker fees from Merck and Takeda, and is a VADT investigator and principal investigator of ancillary study to VADT.

PY - 2009/1

Y1 - 2009/1

UR - http://www.scopus.com/inward/record.url?scp=63149103614&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=63149103614&partnerID=8YFLogxK

U2 - 10.2337/dc08-9026

DO - 10.2337/dc08-9026

M3 - Article

C2 - 19092168

AN - SCOPUS:63149103614

SN - 0149-5992

VL - 32

SP - 187

EP - 192

JO - Diabetes care

JF - Diabetes care

IS - 1

ER -

Intensive glycemic control and the prevention of cardiovascular events: Implications of the ACCORD, ADVANCE, and VA diabetes trials

Funding

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this